TPG Group Holdings (SBS) Advisors’s Genomic Health, Inc. GHDX Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-260,273	Closed	-$6.74M	–	57
2016 Q2	$6.74M	Hold	260,273	–	–	0.07%	48
2016 Q1	$6.45M	Hold	260,273	–	–	0.06%	43
2015 Q4	$9.16M	Hold	260,273	–	–	0.07%	40
2015 Q3	$5.51M	Hold	260,273	–	–	0.03%	44
2015 Q2	$7.23M	Hold	260,273	–	–	0.03%	40
2015 Q1	$7.95M	Hold	260,273	–	–	0.04%	35
2014 Q4	$8.32M	Sell	260,273 -650,000	-71%	-$21.2M	0.05%	33
2014 Q3	$25.8M	Hold	910,273	–	–	0.17%	20
2014 Q2	$24.9M	Hold	910,273	–	–	0.16%	18
2014 Q1	$24M	Hold	910,273	–	–	0.25%	17
2013 Q4	$26.6M	Hold	910,273	–	–	0.32%	16
2013 Q3	$27.8M	Hold	910,273	–	–	0.35%	12
2013 Q2	$28.9M	Buy	+910,273	New	+$29.9M	0.34%	13

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's GHDX Position: Q3 2016 in Review

TPG Group Holdings (SBS) Advisors sold out of Genomic Health, Inc. (GHDX) in Q3 2016, closing a stake of 260,273 shares — an estimated $6.74M sold.

TPG Group Holdings (SBS) Advisors first reported a position in GHDX in Q2 2013 and held it in 13 quarters. The position peaked at $28.9M in Q2 2013. 134 funds tracked by Wall St. Rank hold GHDX as of Q3 2016.

TPG Group Holdings (SBS) Advisors reported no remaining Genomic Health, Inc. position as of Q3 2016 after selling out during the quarter.
TPG Group Holdings (SBS) Advisors sold 260,273 Genomic Health, Inc. shares in Q3 2016, an estimated $6.74M.
TPG Group Holdings (SBS) Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 13 quarters.
TPG Group Holdings (SBS) Advisors's Genomic Health, Inc. position peaked at $28.9M in Q2 2013.
134 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2016.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.